$2.14
-0.01(-0.47%)
Mkt Cap $2M
$1.65
$33.20
52-Week Range
At a Glance
AI-generated8-K
Aethlon Medical, Inc. reported financial results for its fiscal third quarter ended December 31, 2025, including a net loss of $2.02 million and a cash balance of $7.0 million, while providing updates on clinical trial progress and operational cost efficiencies.$2M
Market Cap
—
Revenue
-$11M
Net Income
Employees14
Fundamentals
How The Business Makes Money
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
Industry Medical - Devices
Activity
What Changed Recently
Analyst View
Company Profile
CIK0000882291
ISINUS00808Y6041
Phone619 941 0360
Address11555 Sorrento Valley Road, San Diego, CA, 92121, US
SEC EDGAR